SCHEMBL5234022

SCHEMBL5234022

CC1CCC(C(=O)N(c2nn(-c3ccc(C(=O)Nc4ccc(F)cc4)cc3)cc2C(=O)O)C(C)C)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.44
MEN1 O00255 6/20 0.44
RAB9A P51151 4/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPT P10636 3/20 0.39
LMNA P02545 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MITF O75030 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 2/20 0.38
TP53 P04637 1/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
NAMPT P43490 1/20 0.38
UBE2N P61088 1/20 0.37
POLB P06746 1/20 0.37
HTR1F P30939 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5232510 1.00 KMT2A (0.44) KMT2AMEN1RAB9AALDH1A1MAPT
SCHEMBL5230254 1.00 KMT2A (0.44) KMT2AMEN1RAB9AALDH1A1MAPT
SCHEMBL5230244 1.00 KMT2A (0.44) KMT2AMEN1RAB9AALDH1A1MAPT
SCHEMBL5228931 0.93 MEN1 (0.41) KMT2AMEN1RAB9AALDH1A1MAPT
SCHEMBL5228937 0.93 MEN1 (0.41) KMT2AMEN1RAB9AALDH1A1MAPT
SCHEMBL5230027 0.92 MEN1 (0.41) KMT2AMEN1RAB9AALDH1A1MAPT
SCHEMBL5230020 0.92 MEN1 (0.41) KMT2AMEN1RAB9AALDH1A1MAPT
SCHEMBL5234272 0.90 CA12 (0.34) KMT2AMEN1ALDH1A1HTTPOLB
SCHEMBL5234263 0.90 CA12 (0.34) KMT2AMEN1ALDH1A1HTTPOLB
SCHEMBL5235105 0.89 MAPT (0.41) KMT2AMEN1RAB9AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730116-B1 4-CARBOX PYRAZOLE DERIVATES USEFUL AS ANTI-VIRAL AGENTS SMITHKLINE BEECHAM CORP (US) 2007-09-05 EP claimed
US-20070167507-A1 4-Carbox pyrazole derivatives useful as anti-viral agents GLAXO GROUP LIMITED (GB) 2007-07-19 US claimed
EP-1730116-B1 4-CARBOX PYRAZOLE DERIVATES USEFUL AS ANTI-VIRAL AGENTS SMITHKLINE BEECHAM CORP (US) 2007-09-05 EP disclosed
US-20070167507-A1 4-Carbox pyrazole derivatives useful as anti-viral agents GLAXO GROUP LIMITED (GB) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167507-A1 4-Carbox pyrazole derivatives useful as anti-viral agents HAVCR2, RPL35, ZC3HAV1L KMT2A 4445/4885MEN1 4820/4885RAB9A 1879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.